A $19 Ticket and a $23 Cocktail: How US Open 2026 Exposed the Void in Men's Tennis

At Flushing Meadows, a Honey Deuce — the signature cocktail sold throughout Arthur Ashe Stadium — costs $23. A ticket to the men's singles semifinal between Alexander Zverev and Karen Khachanov, as of Thursday afternoon, cost $19.

I sat in the third row of Louis Armstrong Stadium with the score at 4-2 for Zverev in the first set. Behind me, two men in Buffalo Bills t-shirts debated whether to stay for the whole match or step out for a beer before a football game that evening. They did not know Khachanov's name. They also did not know that Zverev had won Roland-Garros in June, and had reached the semifinals of all four Grand Slams this year. An empty stadium does not just lack noise — it lacks the story being told.

A Grand Slam semifinal between the top seed and a former top-10 player, on a hard court that suits both, should have been unmissable. But when I left the stands at 3 p.m., the eastern rows were still nearly a third empty. This is a men's semifinal at the US Open, a tournament that announced record revenue of $500 million last year. And the ticket was cheaper than a cocktail.

Context: A perfect season nobody watched

Zverev arrived in New York as the top seed. He won Roland-Garros 2026 — the first Grand Slam title of his career at age 29 — then reached the Wimbledon final and lost to an opponent he had never beaten on grass. Reaching the semifinals of all four Grand Slams in a single season is something only a handful of legends since the Open Era have managed: Djokovic, Federer, Nadal, and Murray at their peaks.

At Flushing Meadows, the story was written in a different ink.

Jannik Sinner withdrew before the tournament with a knee injury. Carlos Alcaraz did not enter. Novak Djokovic did not enter. The three players who generate most of men's tennis's media and ticketing demand were all absent. What remained was a draw in which Zverev reached the semifinals without facing a single top-20 opponent — something that has not happened to a top seed at the US Open in at least two decades.

I have covered professional men's tennis for 25 years. I remember the early 2000s, when a Masters Series quarterfinal in Cincinnati could sell out two weeks before the event. But tennis has changed. Not because the quality of players has dropped — but because the way audiences approach the sport has been reshaped by a very small group of names.

Khachanov, Zverev's semifinal opponent, was once top 10 and once won the Paris Masters 1000. This year he is 30, ranked outside the top 40, and has rediscovered his best form in years to reach his first Grand Slam semifinal since 2026. This is the story of a stubborn player finding himself again — but not the story American fans buy tickets to see.

Ticket prices, dynamic pricing, and three layers of cause

What actually happened to ticket prices?

According to aggregated secondary-market data, prices for the men's semifinal fell roughly 89% in three days. From about $35 early in the week, they bottomed at $19 on Thursday afternoon — while the Honey Deuce, the signature drink priced at $23, still sold briskly. This is not an isolated case. UK television analysis showed the 2026 Wimbledon men's final drew just 5.95 million viewers, down from 8.3 million the previous year — the lowest in three years. Two independent signals, ticketing and broadcast, point the same way.

But I want to read these numbers more carefully.

Ticket prices in the US are a product of dynamic pricing, where organizers and secondary platforms adjust prices to supply and demand in real time. When demand is low, prices do not collapse — they adjust to a new equilibrium. The central question is not why tickets are cheap, but why demand was not enough to hold the price.

The answer sits in three layers.

The first layer is the draw. A soft draw is not just easy for the player — it also removes the dramatic material the media needs to sell a story. There is no shock to tell, no battle to remember. When Zverev advanced through the quarterfinals without dropping a set against an opponent outside the top 30, the international conversation was not about his form — it was about his luck. That is a soft-draw signal, and the path was never stress-tested by elite opposition.

The second layer is scheduling. The Zverev-Khachanov match was placed in the afternoon, after the women's doubles final. This was Zverev's first afternoon semifinal of the event. Meanwhile, the all-American semifinal between Ben Shelton and Frances Tiafoe was pushed into prime time. The US Open does not hide its strategy of prioritizing home players for peak slots — and that means a high-quality semifinal can still be commercially demoted. The two-day rest given to Shelton and Tiafoe, compared with Zverev's tighter rhythm, shows the organizers calculated clearly: home appeal matters more than seeding.

The third layer, and the one I consider most important, is the star structure of men's tennis today.

I have written about this many times in recent analyses: men's tennis is in an era of extreme star dependency. Neutral-fan demand — not die-hard fans of any particular player — is concentrated in a very small group: Alcaraz, Sinner, Djokovic. When all three are absent, the depth of the field cannot fill the gap.

Zverev is the top seed. He won a Grand Slam. He reached all four Slam semifinals in a season. By pure results logic, he should be the one drawing the crowds. But tennis does not operate on pure logic.

The divergence between results and market value is the strangest phenomenon of the 2026 season. A player winning the first Grand Slam of his career — something that usually triggers an immediate commercial leap — is selling tickets cheaper than a cocktail. When Federer won his first Wimbledon in 2026, his commercial value more than tripled within a year. When Djokovic completed the career Grand Slam in 2026, his endorsements peaked. With Zverev, that curve did not appear.

There are reasons off the court.

Zverev has faced past domestic-abuse allegations — allegations that seriously damaged his image with part of the public. The ATP investigated and issued no formal sanction, but public memory does not forget. In a sport where personal brand determines commercial value, this stain remains. A top seed with a Grand Slam title should generate elite media pull — the failure to convert that into market demand points to a reputation-management gap, not a results gap.

But I do not want to reduce the whole story to the personal. Even without that issue, I suspect demand would not be much higher — when his semifinal opponent is ranked outside the top 40, and the tournament lacks the three biggest crowd-pullers.

Comparison with women's tennis: a more stable star structure

To see the picture more clearly, place men's and women's tennis side by side at the same event.

US Open 2026 featured Aryna Sabalenka, Iga Swiatek, and Coco Gauff — three of the top four women all entered and all went deep. Their matches sold better. The Gauff-Swiatek semifinal drew higher television viewership than the men's semifinal in the same window. This does not mean women's tennis is more popular — it means the women's star structure is more stable than the men's right now. Sabalenka, Swiatek, and Gauff form a continuous chain: the current dominant player, the former dominant player finding her form again, and the rising young star. Three layers of characters coexist in one tournament, and each layer brings its own story for the audience.

Men's tennis lacked that structure at US Open 2026. Zverev was the dominant player by results but had no young rival face-to-face. Shelton and Tiafoe were home stars, but they are not the natural successors to Alcaraz or Sinner. No middle layer of story filled the space between the top seed and the two Americans.

Back to the court.

In the second set, Zverev served in the third game. His first serve hit 138 mph. Khachanov returned it out. It was one of the best rallies of the match — but the stands only clapped lightly, no roars. I realized neither player carried stadium energy — the kind Federer or Nadal once generated simply by walking onto the court. After a game in the third set, Zverev hit a cross-court forehand and walked back to the baseline, head down. He did not look at the stands. The stands did not look at him.

Here, homogenization is not in playing style — it is in how audiences perceive players. When there are no stars, good players become interchangeable in the eyes of neutral fans. And when everyone is interchangeable, no one is worth paying a premium for. Both Zverev and Khachanov play solid fundamentals, both serve powerfully, both move within systems. Neither has a signature that makes a neutral fan call their name.

The contrarian angle: demand has not disappeared, it has shifted

But I want to challenge the very thesis that men's tennis is dying, which many American writers are using.

At the same tournament, the semifinal between Shelton and Tiafoe was placed in prime time and drew huge interest. Shelton, 23, represents the new wave of American tennis with an explosive style and a theatrical personality. Tiafoe, 28, is the perfect storyteller for American audiences, with a difficult upbringing and a journey up from public courts in Maryland. When the two met, the stadium had no empty seats — not because the match was better than Zverev-Khachanov, but because it had an easier story to sell.

Demand has not disappeared — it has shifted. It shifted toward home players, toward relatable personal stories, and toward the people who showed up at the stadium that day. Zverev's problem, therefore, is not that he is not good enough. It is that he does not have the story the American market is looking for right now: an American on the rise, a legend returning, or a young player with an extraordinary tale.

And here is the truly counterintuitive point: the ticket-price collapse in Zverev-Khachanov is not a sign men's tennis is weakening — it is a sign that the Grand Slam business model depends too heavily on a handful of stars. The US Open was not wrong to schedule the all-American match in prime time; that was a reasonable commercial decision. But that decision exposes a systemic vulnerability: when only a few players can pull crowds, any tournament missing them is in danger.

I have seen something similar in another sport — track and field. After Usain Bolt retired in 2026, 100m events lost a large share of their audiences. Not because the average speed of athletes declined — on the contrary, competitiveness increased. But once neutral fans grow used to a star with special charisma, they struggle to watch just a competition. Their demand attaches to the person, not the sport.

Men's tennis risks the same trap. When Alcaraz, Sinner, and Djokovic play, every one of their matches is an event. When they are absent, the rest of the tournament becomes just tennis. And while other sports can lean on teams — football has clubs, basketball has teams — tennis has only individuals. When the individuals are gone, there is nothing to hold on to.

This does not mean players like Zverev are not good enough to create events. It means they are being judged by a yardstick they do not control — the yardstick of commercial appeal, shaped by media, personal narrative, and timing. Sinner's knee injury may just be an ordinary sporting accident, but its consequence is that an entire draw lost its pull, and a Grand Slam semifinal sold tickets cheaper than a cocktail.

A progressive thought: a question nobody has answered

As I left Flushing Meadows that evening, I thought of something a veteran editor told me more than twenty years ago: Tennis is the sport audiences come to see one person — but they stay for a match.

Zverev did his part. He won his first Grand Slam at 29, reached all four major semifinals, held the top seed. He played well enough to deserve a packed semifinal court. But tennis does not only reward what players do on court. It rewards what the sports world and the market choose to tell about them.

In an era when tournaments depend too heavily on a few stars, rebuilding the depth of this sport — not just technically, but narratively — may be the biggest challenge for men's tennis in the coming decade. A $19 ticket does not say the match was not good. It says nobody has told the story well enough to sell it.